yudilks, I don't think AMRN's SP will move significantly for the next couple of years without success of COVID trials, but I believe AMRN will be successful in 5-10 years regardless of COVID trials. I'm not optimistic for short term (for the next few years), but long term.
Yudilks, The company has not failed you yet. We got bent over in 2012 by FDA. Bent over again in 2020 in Nevada. The story is not over. The investment community can't see beyond the Nevada ruling yet. Sleven,